Views 357
Citations 0
March 2014

Systemic Inflammatory Pseudotumor and Myasthenia Gravis

Author Affiliations
  • 1Scheie Eye Institute, Department of Neurology and Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • 2now with Department of Ophthalmology, University of California, San Francisco
  • 3Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • 4Department of Neurology, NYU Langone Medical Center, New York University, New York

Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Ophthalmol. 2014;132(3):359-361. doi:10.1001/jamaophthalmol.2014.16

We describe a patient with aggressive systemic inflammatory pseudotumor manifesting as isolated ocular myasthenia gravis. In this case, the routine chest imaging performed following the diagnosis of myasthenia gravis identified occult mediastinal lymphoid disease years prior to development of diffuse systemic symptoms.

A 55-year-old man had intermittent left upper eyelid drooping and blurring of vision, worse later in the day, for 6 weeks. He had no significant medical history, no smoking history, and no systemic symptoms. The examination findings were notable for left upper eyelid ptosis with associated fatigability and Cogan twitch; the findings were otherwise normal. Acetylcholine receptor (AchR)–blocking antibody positivity (6.6 μm/L) and abnormal single-fiber electromyography confirmed the diagnosis of myasthenia gravis. Computed tomographic imaging of the chest revealed numerous lung nodules and mediastinal adenopathy, suggesting metastatic disease (Figure 1A).

First Page Preview View Large
First page PDF preview
First page PDF preview